Perioperative Medication Management in the Rheumatic Diseases

Affiliations

Editorial

C Ronald MacKenzie. Curr Rev Musculoskelet Med. 2017 Sep.

. 2017 Sep;10(3):404-406.

doi: 10.1007/s12178-017-9430-7.

¹ Hospital for Special Surgery, 535 East 70th St., New York, NY, 10021, USA. MackenzieR@HSS.edu.

No abstract available

References

1. Mertelsmann-Voss C, Lyman S, Pan TH, et al. US trends in rates of arthroplasty for inflammatory arthritis including rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritis. Arthritis Rheum. 2014;66(6):1432–1439. doi: 10.1002/art.38384. - DOI - PMC - PubMed
1. Nikiphorou E, Carpenter L, Morris S, et al. Hand and foot surgery rates in rheumatoid arthritis have declined from 1986 to 2011, but large-joint replacement rates remain unchanged: results from two UK inception cohorts. Arthritis Rhem. 2014;66(5):1081–1089. doi: 10.1002/art.38344. - DOI - PubMed
1. Mertelssmann-Voss C, Lyuman S, Pan TJ, et al. Arthroplasty rates are increased among US patients with systemic lupus erythematosus: 1991-2005. J Rheumatol. 2014;41(5):867–874. doi: 10.3899/jrheum.130617. - DOI - PubMed
1. Goodman SM, Spinger B, Guyatt G, et al. 2016 American College of Rheumatology/American Association of Hip and Knee Surgeons Guidelines for the perioperative management of anti-rheumatic medication in patients with rheumatic diseases undergoing elective total hip and knee arthroplasty. Arthritis Rheum. 2017. - PubMed
1. Neumann I, Santesso N, Aki EA, et al. A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach. J Clin Epidemiol. 2016;72:45–55. doi: 10.1016/j.jclinepi.2015.11.017. - DOI - PubMed